Anderson et al. [30] described ten patients with progressive CLL after venetoclax (including four cases after successful salvage of Richter transformation) treated with BTK inhibitor therapy, with objective responses in nine cases, although cohort follow up was short. Here, BTK is linked to B-cell chronic lymphocytic leukemia.